Navigation Links
SCAI's Annual Fall Fellows Course Prepares New Interventional Cardiologists to Work in the Field
Date:12/8/2008

sted this course, we have seen 90 percent of the interventional cardiology fellows from the United States, plus others from around the world."

This year, 250 fellows from 18 countries will test their skills and take part in unique hands-on simulations as they prepare to practice in the real world. The fellows also gain a well-rounded and in-depth knowledge of indications, techniques and expected outcomes for interventional cardiac, carotid, structural, congenital and endovascular procedures.

"Today physicians learn and perfect their craft by participating in hands-on activities and simulations," said SCAI Immediate Past President Bonnie Weiner, MD, MSEC, MBA, FSCAI. "This course provides fellows the opportunity to ensure they can perform their every-day job to the best of their ability. Participation in state-of-the-art practices and working with seasoned experts in the field is a totally unique and invaluable experience." Dr. Weiner, Michael J. Cowley, MD, FSCAI, and Christopher U. Cates, MD, FSCAI, are the Program Directors of SCAI's Third Annual Interventional Cardiology Fall Fellows Course.

Throughout the course, sessions cover interventional pharmacology; coronary, carotid, renal, and peripheral intervention; bifurcation lesions; structural heart disease; congenital heart disease; and practice management topics important in establishing an interventional cardiology practice.

The course is provided at no cost to participants, thanks to generous support from Abbott Vascular, Access Closure, ACIST Medical, AGA Medical, Biosense Webster, Inc., Boston Scientific, Cook Medical, Cordis Cardiac & Vascular Institute, Daiichi Sankyo - Eli Lilly, Datascope, Genentech, Immersion, InfraReDx, Medical Simulation Corp., Medtronic, Inc., Mentice, Inc., PICS Foundation, Radi Medical Systems, sanofi aventis, Schering-Plough, Simbionix, St. Jude Medical, Terumo Interventional Systems, The Medicines
'/>"/>

SOURCE Society for Cardiovascular Angiography and Interventions
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Savient Pharmaceuticals to Present at the 27th Annual J.P. Morgan Healthcare Conference on January 14th
2. Late-breaking data to be presented at the American Society of Hematology Annual Meeting
3. Hologic to Present at the J.P. Morgan 27th Annual Healthcare Conference
4. REGiMMUNE to present GvHD data at the 50th ASH Annual Meeting
5. Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto
6. How to Ensure Your Companys Survival: Leaders to Discuss at the 11th Annual Customer Experience Conference in Las Vegas
7. MaxCyte to Present Targeted Cancer Immunotherapy Product at 50th Annual Meeting of the American Society of Hematology
8. Nu Skin Enterprises Offers 2009 Guidance During Annual Investor Day
9. 50th Annual Meeting of the American Society of Hematology Will Feature Breakthrough Research in Blood Diseases
10. HLTH Corporation and WebMD to Webcast Annual Meetings of Stockholders
11. Stryker Increases Annual Dividend by Over 20%
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... revitalized and expanded through a U.S.-funded effort that ... access and providing cutting-edge skills labs and other ... by participants of the $130 million Medical Education ... progress being made at the African institutions. Their ... by the journal Academic Medicine . Begun ...
(Date:7/30/2014)... Alan Mozes HealthDay Reporter ... who want to help their preschooler shed excess pounds may ... Youngsters whose parents joined them in a supervised behavioral ... enrolled in a traditional child-only program (an average difference of ... benefited, losing almost 15 pounds over two years, according to ...
(Date:7/30/2014)... July 30, 2014 The family of ... has filed a Xarelto lawsuit ( http://www.xareltolawsuitcenter.com/ ) ... Bernstein Liebhard LLP reports. According to the complaint, which ... of Vermont on July 25th, the decedent had been ... an irreversible brain bleed that ultimately led to his ...
(Date:7/30/2014)... 2014) The phrase "we caught it early" is possibly ... midst of a cancer diagnosis. Combating cancer in its ... certain part of the body, gives patients the best ... colon, prostate and other forms of cancer are touted ... providers recommend cancer screenings as a precautionary measure, especially ...
(Date:7/30/2014)... The Ehlers-Danlos National Foundation (EDNF) is pleased ... Chack will serve as chair. The board was voted ... Learning Conference in Houston, Texas July 10-12. , ... of us. From the rollout of the first EDNF ... Baltimore Medical Center to our September physicians conference to ...
Breaking Medicine News(10 mins):Health News:Journal supplement details progress in African medical education 2Health News:Journal supplement details progress in African medical education 3Health News:Make Kids' Weight Loss a Family Affair, Study Suggests 2Health News:Make Kids' Weight Loss a Family Affair, Study Suggests 3Health News:Make Kids' Weight Loss a Family Affair, Study Suggests 4Health News:Xarelto Lawsuit Alleges Man’s Death from Uncontrollable Brain Bleeding Was Caused by Xarelto, Bernstein Liebhard LLP Reports 2Health News:Xarelto Lawsuit Alleges Man’s Death from Uncontrollable Brain Bleeding Was Caused by Xarelto, Bernstein Liebhard LLP Reports 3Health News:UK psychologist creates patient tool to assist with lung cancer screening decision 2Health News:UK psychologist creates patient tool to assist with lung cancer screening decision 3Health News:Ehlers-Danlos National Foundation Announces New Leadership 2
... in China is smaller than that of many other countries, ... diabetics// of age between 20 and 79 in 2003. ... in China, while diabetics are mostly aged between 60 to ... Department in Beijing University People's Hospital. ,"Although no ...
... the Mecca of Fashion, Paris, have uncovered a mechanism ... natural chemical called opiorphin//, a natural pain alleviator, far ... their experiments, rodents were found to experience pain relief ... with the usual dosage of morphine. The finding which ...
... with incriminating evidence that warns non-vegetarians who binge on red ... out that eating more than one and a half servings ... breast cancer and another study that vitamin supplements seem ... diseases except for vitamin C which seems to show some ...
... fatty acid known as docosahexaenoic acid (DHA) in their ... dementia and Alzheimer’s disease, according to a study. ... been found to increase the risk of dementia and ... of cases of dementia in the elderly, according to ...
... Shelnutt and Yujiang Song from Sandia National Laboratories have ... attaches //to a cell which involves a new process that ... Security Administration laboratory. ,An upcoming issue of the German ... Angewandte Chemie Int. Ed which has currently published the same ...
... be just a matter of eating a salad a day. ... Americans will welcome a new study that could keep them ... study, conducted by the UCLA School of Public Health and ... revealed eating salads with salad dressing and raw vegetables is ...
Cached Medicine News:Health News:Red alert to women against red meat consumption 2Health News:Higher Level of Certain Fatty Acid Associated with Lower Dementia Risk 2Health News:Novel methods to view how a drug attaches to a cell 2Health News:A Salad a Day Keeps the Doctor Away This Winter 2
(Date:7/30/2014)... PITTSBURGH , July 30, 2014   ... Markets Groups Inc.: OTC Pink: UPZS), a Delaware ... a distribution agreement with Larasan Pharmaceutical Corporation ("Larasan"), a ... products.  According to the agreement, US-based Larasan will ... gourmet 6" frozen pizza through Larasan,s vast distribution ...
(Date:7/30/2014)... KISSING, Germany , July 30, 2014 ... single use and computer-assisted ("robotic") colonoscopy system, today announced ... worldwide recognized medical device executive, as a new member ... is a highly respected global visionary in the medical ... as President and Chief Executive Officer at Given Imaging ...
(Date:7/30/2014)... and PARIS , July 30, ... ) and Sanofi (EURONEXT: SAN and NYSE: ... ODYSSEY trials of alirocumab in people with hypercholesterolemia met ... from baseline in low-density lipoprotein cholesterol (LDL-C) at 24 ... an investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin ...
Breaking Medicine Technology:Unique Pizza and Subs Announces Asian Distribution Agreement with Larasan Pharmaceutical Corporation 2Unique Pizza and Subs Announces Asian Distribution Agreement with Larasan Pharmaceutical Corporation 3invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 2invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 4Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 6Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 7Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 8
... 2011 Thoratec Corporation (NASDAQ: THOR ... support therapies to save, support and restore failing ... WiTricity Corporation relating to WiTricity,s proprietary wireless resonant ... of mechanical circulatory support. Through a ...
... Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) today ... 2011, and reviewed recent developments. "In collaboration ... support the submission of our response to the FDA,s complete ... Lief, Arena,s President and Chief Executive Officer. "We are also ...
Cached Medicine Technology:Thoratec Announces Development Agreement With WiTricity for Proprietary Energy Transfer Technology 2Thoratec Announces Development Agreement With WiTricity for Proprietary Energy Transfer Technology 3Thoratec Announces Development Agreement With WiTricity for Proprietary Energy Transfer Technology 4Arena Pharmaceuticals Announces First Quarter 2011 Financial Results and Recent Developments 2Arena Pharmaceuticals Announces First Quarter 2011 Financial Results and Recent Developments 3Arena Pharmaceuticals Announces First Quarter 2011 Financial Results and Recent Developments 4Arena Pharmaceuticals Announces First Quarter 2011 Financial Results and Recent Developments 5Arena Pharmaceuticals Announces First Quarter 2011 Financial Results and Recent Developments 6Arena Pharmaceuticals Announces First Quarter 2011 Financial Results and Recent Developments 7Arena Pharmaceuticals Announces First Quarter 2011 Financial Results and Recent Developments 8
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: